Medical education in the United States; 1910-1956.

S. Jarcho

1959-07-01

Abstract:

What problem does this paper attempt to address?

Setd2, A H3k36 Lysine Methyltransferase, is Essential for Adult Normal Hematopoiesis and Leukemia Stem Cells

Yile Zhou,Yunzhu Dong,Jiachen Bu,Xiaomei Yan,Yoshihiro Hayashi,Qianfei Wang,Jie Jin,Gang Huang

DOI: https://doi.org/10.1182/blood.v128.22.1055.1055

IF: 20.3

2016-01-01

Blood

Abstract:Hematopoietic stem cells (HSCs) are characterized by their capability for self-renewal and multi-potency. Hematopoiesis is dynamically controlled by the interplay between epigenetic and transcriptional networks. Dysregulation of these networks can lead to unfitness of hematopoiesis, cell transformation, and hematological diseases. The human SETD2 gene was originally isolated from HSCs and progenitors. SETD2 is a histone methyltransferase, which specifically catalyzes tri-methylation of histone 3 lysine 36 (H3K36me3). SETD2 functions as a tumor suppressor, as loss-of-function mutations have been identified in many cancers. However, the role of SETD2 in hematopoiesis has not been fully understood.
Setd2 Regulates Quiescence and Differentiation of Adult Hematopoietic Stem Cells by Restricting RNA Polymerase II Elongation.

Yile Zhou,Xiaomei Yan,Xiaomin Feng,Jiachen Bu,Yunzhu Dong,Peipei Lin,Yoshihiro Hayashi,Rui Huang,Andre Olsson,Paul R. Andreassen,H. Leighton Grimes,Qian-fei Wang,Tao Cheng,Zhijian Xiao,Jie Jin,Gang Huang

DOI: https://doi.org/10.3324/haematol.2018.187708

2018-01-01

Haematologica

Abstract:SET domain containing 2 (Setd2), encoding a histone methyltransferase, is associated with many hematopoietic diseases when mutated. By generating a novel exon 6 conditional knockout mouse model, we describe an essential role of Setd2 in maintaining the adult hematopoietic stem cells. Loss of Setd2 results in leukopenia, anemia, and increased platelets accompanied by hypocellularity, erythroid dysplasia, and mild fibrosis in bone marrow. Setd2 knockout mice show significantly decreased hematopoietic stem and progenitor cells except for erythroid progenitors. Setd2 knockout hematopoietic stem cells fail to establish long-term bone marrow reconstitution after transplantation because of the loss of quiescence, increased apoptosis, and reduced multiple-lineage terminal differentiation potential. Bioinformatic analysis revealed that the hematopoietic stem cells exit from quiescence and commit to differentiation, which lead to hematopoietic stem cell exhaustion. Mechanistically, we attribute an important Setd2 function in murine adult hematopoietic stem cells to the inhibition of the Nsd1/2/3 transcriptional complex, which recruits super elongation complex and controls RNA polymerase II elongation on a subset of target genes, including Myc Our results reveal a critical role of Setd2 in regulating quiescence and differentiation of hematopoietic stem cells through restricting the NSDs/SEC mediated RNA polymerase II elongation.
Methyltransferase Setd2 Prevents T Cell-Mediated Autoimmune Diseases Via Phospholipid Remodeling

Yali Chen,Kun Chen,Ha Zhu,Hua Qin,Juan Liu,Xuetao Cao

DOI: https://doi.org/10.1073/pnas.2314561121

2024-01-01

Abstract:Coordinated metabolic reprogramming and epigenetic remodeling are critical for modulating T cell function and differentiation. However, how the epigenetic modification controls Th17/Treg cell balance via metabolic reprogramming remains obscure. Here, we find that Setd2, a histone H3K36 trimethyltransferase, suppresses Th17 development but promotes iTreg cell polarization via phospholipid remodeling. Mechanistically, Setd2 up-regulates transcriptional expression of lysophosphatidylcholine acyltransferase 4 (Lpcat4) via directly catalyzing H3K36me3 of Lpcat4 gene promoter in T cells. Lpcat4-mediated phosphatidylcholine PC(16:0,18:2) generation in turn limits endoplasmic reticulum stress and oxidative stress. These changes decrease HIF-1α transcriptional activity and thus suppress Th17 but enhance Treg development. Consistent with this regulatory paradigm, T cell deficiency of Setd2 aggravates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis due to imbalanced Th17/Treg cell differentiation. Overall, our data reveal that Setd2 acts as an epigenetic brake for T cell-mediated autoimmunity through phospholipid remodeling, suggesting potential targets for treating neuroinflammatory diseases.
Substrate Specificity for Human Histidine Methyltransferase SETD3

Jordi C. J. Hintzen,Huida Ma,Hao Deng,Apolonia Witecka,Steffen B. Andersen,Jakub Drozak,Hong Guo,Ping Qian,Haitao Li,Jasmin Mecinović

DOI: https://doi.org/10.1101/2021.12.30.474520

2021-01-01

bioRxiv

Abstract:Histidine methyltransferase SETD3 plays an important role in human biology and diseases. Previously, we showed that SETD3 catalyzes N3-methylation of histidine 73 in β-actin (Kwiatkowski et al., 2018). Here we report integrated synthetic, biocatalytic, biostructural and computational analyses on human SETD3-catalyzed methylation of β-actin peptides possessing histidine and its structurally and chemically diverse mimics. Our enzyme assays supported by biostructural analyses demonstrate that SETD3 has a broader substrate scope beyond histidine, including N-nucleophiles on the aromatic and aliphatic side chains. Quantum mechanical/molecular mechanical (QM/MM) molecular dynamics and free-energy simulations provide insight into binding geometries and the free energy barrier for the enzymatic methyl transfer to histidine mimics, further supporting experimental data that histidine is the superior SETD3 substrate over its analogs. This work demonstrates that human SETD3 has a potential to catalyze efficient methylation of several histidine mimics, overall providing mechanistic, biocatalytic and functional insight into β-actin histidine methylation by SETD3.
Histidine Methyltransferase SETD3 Methylates Structurally Diverse Histidine Mimics in Actin

Jordi C. J. Hintzen,Huida Ma,Hao Deng,Apolonia Witecka,Steffen B. Andersen,Jakub Drozak,Hong Guo,Ping Qian,Haitao Li,Jasmin Mecinovic

DOI: https://doi.org/10.1002/pro.4305

IF: 8

2022-01-01

Protein Science

Abstract:Actin histidine Nτ‐methylation by histidine methyltransferase SETD3 plays an important role in human biology and diseases. Here, we report integrated synthetic, biocatalytic, biostructural, and computational analyses on human SETD3‐catalyzed methylation of actin peptides possessing histidine and its structurally and chemically diverse mimics. Our enzyme assays supported by biostructural analyses demonstrate that SETD3 has a broader substrate scope beyond histidine, including N‐nucleophiles on the aromatic and aliphatic side chains. Quantum mechanical/molecular mechanical molecular dynamics and free‐energy simulations provide insight into binding geometries and the free energy barrier for the enzymatic methyl transfer to histidine mimics, further supporting experimental data that histidine is the superior SETD3 substrate over its analogs. This work demonstrates that human SETD3 has a potential to catalyze efficient methylation of several histidine mimics, overall providing mechanistic, biocatalytic, and functional insight into actin histidine methylation by SETD3.
A New Data Mining Approach for the Detection of Bacterial Promoters Combining Stochastic and Combinatorial Methods

Catherine Eng,C. Asthana,B. Aigle,Sébastien Hergalant,Jean-François Mari,P. Leblond

DOI: https://doi.org/10.1089/cmb.2008.0122

2009-09-01

Abstract:We present a new data mining method based on stochastic analysis (Hidden Markov Model [HMM]) and combinatorial methods for discovering new transcriptional factors in bacterial genome sequences. Sigma factor binding sites (SFBSs) were described as patterns of box1-spacer-box2 corresponding to the -35 and -10 DNA motifs of bacterial promoters. We used a high-order HMM in which the hidden process is a second-order HMM chain. Applied on the genome of the model bacterium Streptomyces coelicolor A3(2), the a posteriori state probabilities revealed local maxima or peaks whose distribution was enriched in the intergenic sequences ("iPeaks" for intergenic peaks). Short DNA sequences underlying the iPeaks were extracted and clustered by a hierarchical classification algorithm based on the SmithWaterman local similarity. Some selected motif consensuses were used as box1 (-35 motif ) in the search of a potential neighbouring box2 (-10 motif ) using a word enumeration algorithm. This new SFBS mining methodology applied on Streptomyces coelicolor was successful to retrieve already known SFBSs and to suggest new potential transcriptional factor binding sites (TFBSs). The well-defined SigR regulon (oxidative stress response) was also used as a test quorum to compare first- and second-order HMM. Our approach also allowed the preliminary detection of known SFBSs in Bacillus subtilis.
Molecular Basis for Oncohistone H3 Recognition by SETD2 Methyltransferase

Shuang Yang,Xiangdong Zheng,Chao Lu,Guo-Min Li,C. David Allis,Haitao Li

DOI: https://doi.org/10.1101/gad.284323.116

IF: 12.89

2016-01-01

Genes & Development

Abstract:High-frequency point mutations of genes encoding histones have been identified recently as novel drivers in a number of tumors. Specifically, the H3K36M/I mutations were shown to be oncogenic in chondroblastomas and undifferentiated sarcomas by inhibiting H3K36 methyltransferases, including SETD2. Here we report the crystal structures of the SETD2 catalytic domain bound to H3K36M or H3K36I peptides with SAH (S-adenosylhomocysteine). In the complex structure, the catalytic domain adopts an open conformation, with the K36M/I peptide snuggly positioned in a newly formed substrate channel. Our structural and biochemical data reveal the molecular basis underying oncohistone recognition by and inhibition of SETD2.
Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton

Christina Michail,Fernando Rodrigues Lima,Mireille Viguier,Frédérique Deshayes

DOI: https://doi.org/10.1016/j.neo.2024.101090

IF: 6.218

2024-11-29

Neoplasia

Abstract:SETD2 is known to be the unique histone methyltransferase responsible for the trimethylation of the lysine 36 of histone H3 thus generating H3K36me3. This epigenetic mark is critical for transcriptional activation and elongation, DNA repair, mRNA splicing, and DNA methylation. Recurrent SETD2-inactivating mutations and altered H3K36me3 levels are found in cancer at high frequency and numerous studies indicate that SETD2 acts as a tumor suppressor. Recently, SETD2 was further shown to methylate non-histone proteins particularly the cytoskeletal proteins tubulin and actin with subsequent impacts on cytoskeleton structure, mitosis and cell migration.Herein, we provide a review of the role of SETD2 in different cancers with special emphasis on the structural basis of the functions of this key lysine methyltransferase. Moreover, beyond the role of this enzyme in epigenetics and H3K36me3-dependent processes, we highlight the putative role of "non-epigenetic/H3K36me3" functions of SETD2 in cancer, particularly those involving the cytoskeleton.

oncology
SETDB1 activity is globally directed by H3K14 acetylation via its Triple Tudor Domain

Thyagarajan T. Chandrasekaran,Michel Choudalakis,Alexander Bröhm,Sara Weirich,Alexandra G Kouroukli,Ole Ammerpohl,Philipp Rathert,Pavel Bashtrykov,Albert Jeltsch

DOI: https://doi.org/10.1101/2024.04.22.590554

2024-04-22

Abstract:SETDB1 is a major H3K9 methyltransferase involved in heterochromatin formation and silencing of repeat elements. It contains a unique Triple Tudor Domain (3TD) which specifically binds the dual modification of H3K14ac in the presence of H3K9me1/2/3. Here, we explored the role of the 3TD H3-tail interaction for the H3K9 methylation activity of SETDB1. We generated a binding reduced 3TD mutant and demonstrate in biochemical methylation assays on peptides and recombinant nucleosomes containing H3K14ac analogs, that H3K14 acetylation is crucial for the 3TD mediated recruitment of SETDB1. We also observe this effect in cells where SETDB1 binding and activity is globally correlated with H3K14ac, and KO of the H3K14 acetyltransferase HBO1 causes a drastic reduction in H3K9me3 levels at SETDB1 dependent sites. Further analyses revealed that 3TD particularly important at specific target regions like L1M repeat elements, where SETDB1 KO cannot be efficiently reconstituted by the 3TD mutant of SETDB1. In summary, our data demonstrate that the H3K9me3 and H3K14ac are not antagonistic marks but rather the presence of H3K14ac is required for SETDB1 recruitment via 3TD binding to H3K9me1/2/3-K14ac and establishment of H3K9me3.

Biochemistry
H3K36 trimethylation-mediated biological functions in cancer

Chu Xiao,Tao Fan,He Tian,Yujia Zheng,Zheng Zhou,Shuofeng Li,Chunxiang Li,Jie He

DOI: https://doi.org/10.1186/s13148-021-01187-2

2021-10-29

Clinical Epigenetics

Abstract:Abstract Histone modification is an important form of epigenetic regulation. Thereinto, histone methylation is a critical determination of chromatin states, participating in multiple cellular processes. As a conserved histone methylation mark, histone 3 lysine 36 trimethylation (H3K36me3) can mediate multiple transcriptional-related events, such as the regulation of transcriptional activity, transcription elongation, pre-mRNA alternative splicing, and RNA m 6 A methylation. Additionally, H3K36me3 also contributes to DNA damage repair. Given the crucial function of H3K36me3 in genome regulation, the roles of H3K36me3 and its sole methyltransferase SETD2 in pathogenesis, especially malignancies, have been emphasized in many studies, and it is conceivable that disruption of histone methylation regulatory network composed of “writer”, “eraser”, “reader”, and the mutation of H3K36me3 codes have the capacity of powerfully modulating cancer initiation and development. Here we review H3K36me3-mediated biological processes and summarize the latest findings regarding its role in cancers. We highlight the significance of epigenetic combination therapies in cancers.

oncology,genetics & heredity
SET Domain Proteins in Plants

Jiang-Hua Song,Jia-Shu Cao

DOI: https://doi.org/10.3969/j.issn.1674-7666.2007.03.017

2007-01-01

Abstract:SET domain proteins contain conserved SET domains, which intensively involved in histone methylation. Histone modification plays an important part in transcriptional regulation in plants emerging as a central theme in the control of gene expression. SET domain proteins have been extensively studied in recent years, which are required to elucidate the mechanism of histone modification. In this review, the conserved structure and evolu-tionary mechanism of SET domain proteins in plants was first described. Furthermore, their complex biological functions were discussed, involved in the condensation and isolation of chromosome, the transcription of gene, and the replication and repair of DNA, and so on. It is revealed that SET domain proteins in plants are important for determining epigenetic regulation of gene expression and plant development.
SETD3 is a positive regulator of DNA-damage-induced apoptosis

Elina Abaev-Schneiderman,Lee Admoni-Elisha,Dan Levy

DOI: https://doi.org/10.1038/s41419-019-1328-4

2019-01-25

Cell Death and Disease

Abstract:SETD3 is a member of the protein lysine methyltransferase (PKMT) family, which catalyzes the addition of methyl group to lysine residues. However, the protein network and the signaling pathways in which SETD3 is involved remain largely unexplored. In the current study, we show that SETD3 is a positive regulator of DNA-damage-induced apoptosis in colon cancer cells. Our data indicate that depletion of SETD3 from HCT-116 cells results in a significant inhibition of apoptosis after doxorubicin treatment. Our results imply that the positive regulation is sustained by methylation, though the substrate remains unknown. We present a functional cross-talk between SETD3 and the tumor suppressor p53. SETD3 binds p53 in cells in response to doxorubicin treatment and positively regulates p53 target genes activation under these conditions. Mechanistically, we provide evidence that the presence of SETD3 and its catalytic activity is required for the recruitment of p53 to its target genes. Finally, Kaplan–Meier survival analysis, of two-independent cohorts of colon cancer patients, revealed that low expression of SETD3 is a reliable predictor of poor survival in these patients, which correlates with our findings. Together, our data uncover a new role of the PKMT SETD3 in the regulation of p53-dependent activation of apoptosis in response to DNA damage.

cell biology
Biological processes and signal transduction pathways regulated by the protein methyltransferase SETD7 and their significance in cancer

Inês de Albuquerque Almeida Batista,Luisa Alejandra Helguero

DOI: https://doi.org/10.1038/s41392-018-0017-6

IF: 39.3

2018-07-13

Signal Transduction and Targeted Therapy

Abstract:Protein methyltransferases have been shown to methylate histone and non-histone proteins, leading to regulation of several biological processes that control cell homeostasis. Over the past few years, the histone-lysine N-methyltransferase SETD7 (SETD7; also known as SET7/9, KIAA1717, KMT7, SET7, SET9) has emerged as an important regulator of at least 30 non-histone proteins and a potential target for the treatment of several human diseases. This review discusses current knowledge of the structure and subcellular localization of SETD7, as well as its function as a histone and non-histone methyltransferase. This work also underlines the putative contribution of SETD7 to the regulation of gene expression, control of cell proliferation, differentiation and endoplasmic reticulum stress, which indicate that SETD7 is a candidate for novel targeted therapies with the aim of either stimulating or inhibiting its activity, depending on the cell signaling context.

biochemistry & molecular biology,cell biology
The function of histone methyltransferase SETDB1 and its roles in liver cancer

Enxiang Zhang,Pingping He

DOI: https://doi.org/10.3389/fcell.2024.1500263

IF: 5.5

2024-11-09

Frontiers in Cell and Developmental Biology

Abstract:Epigenetic alterations in gene expression have been implicated in cancer development and tumor immune escape, with posttranslational histone or non-histone modifications representing attractive targets for disease surveillance and therapy. SET domain bifurcated 1 (SETDB1) is a histone lysine methyltransferase that reversibly catalyzes the di- and tri-methylation of histone 3 lysine 9 (H3K9) on euchromatin, inhibiting gene transcription within these regions and facilitating the switch from euchromatic to heterochromatic states. Emerging evidence suggests that SETDB1 amplification and aberrant activation are significantly associated with poor prognosis in hepatocellular carcinoma (HCC), and contribute to HCC development, immune escape, and immune checkpoint blockade (ICB) resistance. Here, we provide an updated overview of the cellular and molecular effects of SETDB1 activity in hepatocarcinogenesis and progression and focus on studies linking its function to immunotherapy for HCC, and present current challenges and future perspectives for targeting SETDB1 in HCC treatment.

cell biology,developmental biology
Histone methyltransferase protein SETD2 interacts with p53 and selectively regulates its downstream genes

Ping Xie,Chunyan Tian,Liguo An,Jing Nie,Kefeng Lu,Guichun Xing,Lingqiang Zhang,Fuchu He

DOI: https://doi.org/10.1016/j.cellsig.2008.05.012

IF: 4.85

2008-01-01

Cellular Signalling

Abstract:SETD2 (SET domain containing protein 2) is a histone H3K36 trimethyltransferase protein that associates with hyperphosphorylated RNA polymerase II and involves in transcriptional elongation. However, whether and how SETD2 is implicated in the specific regulation of gene transcription remains unknown. Here we show that SETD2 could interact with p53 and selectively regulate the transcription factor activity of p53. The interaction was dependent of C-terminal region of SETD2, which contains the SET and WW domains, and the N-terminal transactivation domain (residues 1–45) of p53. Overexpression of SETD2 upregulated the expression levels of a subset of p53 targets including puma, noxa, p53AIP1, fas, p21, tsp1, huntingtin, but downregulated that of hdm2. In contrast, it had no significant effect on those of 14-3-3σ, gadd45 and pig3. Consistently, knockdown of endogenous SETD2 expression by RNA interference resulted in converse effects as expected. In p53-deficient H1299 cells, SETD2 lost the ability to regulate these gene expression except hdm2, indicating the dependence of p53. Furthermore, we demonstrated that SETD2 downregulated hdm2 expression by targeting its P2 promoter and then enhanced p53 protein stability. Collectively, these findings suggest that the histone methyltransferase SETD2 could selectively regulate the transcription of subset genes via cooperation with the transcription factor p53.
Lysine-specific methyltransferase Set7/9 in stemness, differentiation, and development

Alexandra Daks,Sergey Parfenyev,Oleg Shuvalov,Olga Fedorova,Alexander Nazarov,Gerry Melino,Nickolai A. Barlev

DOI: https://doi.org/10.1186/s13062-024-00484-z

2024-05-30

Biology Direct

Abstract:The enzymes performing protein post-translational modifications (PTMs) form a critical post-translational regulatory circuitry that orchestrates literally all cellular processes in the organism. In particular, the balance between cellular stemness and differentiation is crucial for the development of multicellular organisms. Importantly, the fine-tuning of this balance on the genetic level is largely mediated by specific PTMs of histones including lysine methylation. Lysine methylation is carried out by special enzymes (lysine methyltransferases) that transfer the methyl group from S-adenosyl-L-methionine to the lysine residues of protein substrates. Set7/9 is one of the exemplary protein methyltransferases that however, has not been fully studied yet. It was originally discovered as histone H3 lysine 4-specific methyltransferase, which later was shown to methylate a number of non-histone proteins that are crucial regulators of stemness and differentiation, including p53, pRb, YAP, DNMT1, SOX2, FOXO3, and others. In this review we summarize the information available to date on the role of Set7/9 in cellular differentiation and tissue development during embryogenesis and in adult organisms. Finally, we highlight and discuss the role of Set7/9 in pathological processes associated with aberrant cellular differentiation and self-renewal, including the formation of cancer stem cells.

biology
SETD2 in cancer: functions, molecular mechanisms, and therapeutic regimens

Weng,Y.,Xue,J.,Niu,N.

DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0201

2024-09-20

Cancer Biology and Medicine

Abstract:In recent years, the histone methyltransferase SET domain containing 2 (SETD2) has garnered significant attention for its involvement in carcinogenesis. Herein we aim to summarize the research advances regarding SETD2 in tumors, elucidate the role in global epigenetic regulation, highlight potential

oncology,medicine, research & experimental
Structural Biology of Human H3K9 Methyltransferases

Hong Wu,Jinrong Min,Vladimir V. Lunin,Tatiana Antoshenko,Ludmila Dombrovski,Hong Zeng,Abdellah Allali-Hassani,Valérie Campagna-Slater,Masoud Vedadi,Cheryl H. Arrowsmith,Alexander N. Plotnikov,Matthieu Schapira

DOI: https://doi.org/10.1371/journal.pone.0008570

IF: 3.7

2010-01-11

PLoS ONE

Abstract:SET domain methyltransferases deposit methyl marks on specific histone tail lysine residues and play a major role in epigenetic regulation of gene transcription. We solved the structures of the catalytic domains of GLP, G9a, Suv39H2 and PRDM2, four of the eight known human H3K9 methyltransferases in their apo conformation or in complex with the methyl donating cofactor, and peptide substrates. We analyzed the structural determinants for methylation state specificity, and designed a G9a mutant able to tri-methylate H3K9. We show that the I-SET domain acts as a rigid docking platform, while induced-fit of the Post-SET domain is necessary to achieve a catalytically competent conformation. We also propose a model where long-range electrostatics bring enzyme and histone substrate together, while the presence of an arginine upstream of the target lysine is critical for binding and specificity.ENHANCED VERSION: This article can also be viewed as an enhanced version in which the text of the article is integrated with interactive 3D representations and animated transitions. Please note that a web plugin is required to access this enhanced functionality. Instructions for the installation and use of the web plugin are available in Text S1.

multidisciplinary sciences
SETDB1 deletion causes DNA demethylation and upregulation of multiple zinc-finger genes

Yong-Kook Kang,Jaemin Eom,Byungkuk Min,Jung Sun Park

DOI: https://doi.org/10.1007/s11033-024-09703-2

IF: 2.7422

2024-06-23

Molecular Biology Reports

Abstract:SETDB1 (SET domain bifurcated-1) is a histone H3-lysine 9 (H3K9)-specific methyltransferase that mediates heterochromatin formation and repression of target genes. Despite the assumed functional link between DNA methylation and SETDB1-mediated H3K9 trimethylations, several studies have shown that SETDB1 operates autonomously of DNA methylation in a region- and cell-specific manner. This study analyzes SETDB1 -null HAP1 cells through a linked methylome and transcriptome analysis, intending to explore genes controlled by SETDB1-involved DNA methylation.

biochemistry & molecular biology
Proteome Identification of Proteins Interacting with Histone Methyltransferase SET8.

Yi Qin,Huafang Ouyang,Jing Liu,Youhua Xie

DOI: https://doi.org/10.1093/abbs/gmt011

IF: 3.7

2013-01-01

Acta Biochimica et Biophysica Sinica

Abstract:SET8 (also known as PR-Set7/9, SETD8, KMT5A), a member of the SET domain containing methyltransferase family, which specifically catalyzes mono-methylation of K20 on histone H4 (H4K20me1), has been implicated in multiple biological processes, such as gene transcriptional regulation, cell cycle control, genomic integrity maintenance and development. In this study, we used GST-SET8 fusion protein as bait to search for SET8 interaction partners to elucidate physiological functions of SET8. In combination with mass spectrometry, we identified 40 proteins that potentially interact with SET8. DDX21, a nucleolar protein, was further confirmed to associate with SET8. Furthermore, we discovered a novel function of SET8 in the regulation of rRNA transcription.

Medical education in the United States; 1910-1956.

Setd2, A H3k36 Lysine Methyltransferase, is Essential for Adult Normal Hematopoiesis and Leukemia Stem Cells

Setd2 Regulates Quiescence and Differentiation of Adult Hematopoietic Stem Cells by Restricting RNA Polymerase II Elongation.

Methyltransferase Setd2 Prevents T Cell-Mediated Autoimmune Diseases Via Phospholipid Remodeling

Substrate Specificity for Human Histidine Methyltransferase SETD3

Histidine Methyltransferase SETD3 Methylates Structurally Diverse Histidine Mimics in Actin

A New Data Mining Approach for the Detection of Bacterial Promoters Combining Stochastic and Combinatorial Methods

Molecular Basis for Oncohistone H3 Recognition by SETD2 Methyltransferase

Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton

SETDB1 activity is globally directed by H3K14 acetylation via its Triple Tudor Domain

H3K36 trimethylation-mediated biological functions in cancer

SET Domain Proteins in Plants

SETD3 is a positive regulator of DNA-damage-induced apoptosis

Biological processes and signal transduction pathways regulated by the protein methyltransferase SETD7 and their significance in cancer

The function of histone methyltransferase SETDB1 and its roles in liver cancer

Histone methyltransferase protein SETD2 interacts with p53 and selectively regulates its downstream genes

Lysine-specific methyltransferase Set7/9 in stemness, differentiation, and development

SETD2 in cancer: functions, molecular mechanisms, and therapeutic regimens

Structural Biology of Human H3K9 Methyltransferases

SETDB1 deletion causes DNA demethylation and upregulation of multiple zinc-finger genes

Proteome Identification of Proteins Interacting with Histone Methyltransferase SET8.